Capital Advisors Inc’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$40.6M Sell
100,222
-102
-0.1% -$41.4K 0.73% 56
2025
Q1
$49.9M Buy
100,324
+830
+0.8% +$413K 0.99% 34
2024
Q4
$51.8M Sell
99,494
-427
-0.4% -$222K 1.03% 33
2024
Q3
$61.8M Buy
99,921
+4,947
+5% +$3.06M 1.24% 23
2024
Q2
$52.5M Buy
94,974
+383
+0.4% +$212K 1.09% 26
2024
Q1
$55M Sell
94,591
-552
-0.6% -$321K 1.18% 21
2023
Q4
$50.5M Buy
95,143
+5,741
+6% +$3.05M 1.13% 27
2023
Q3
$45.3M Buy
89,402
+3,945
+5% +$2M 1.19% 28
2023
Q2
$44.6M Buy
85,457
+6,509
+8% +$3.4M 1.13% 29
2023
Q1
$45.5M Buy
78,948
+2,351
+3% +$1.36M 1.22% 24
2022
Q4
$42.2M Buy
76,597
+870
+1% +$479K 1.2% 28
2022
Q3
$38.1M Sell
75,727
-963
-1% -$484K 1.18% 26
2022
Q2
$41.7M Buy
76,690
+705
+0.9% +$383K 1.25% 24
2022
Q1
$44.9M Sell
75,985
-271
-0.4% -$160K 1.23% 24
2021
Q4
$50.9M Sell
76,256
-5,481
-7% -$3.66M 1.36% 17
2021
Q3
$46.7M Buy
81,737
+3,912
+5% +$2.24M 1.39% 17
2021
Q2
$39.3M Buy
77,825
+4,176
+6% +$2.11M 1.18% 23
2021
Q1
$33.6M Buy
73,649
+122
+0.2% +$55.7K 1.1% 27
2020
Q4
$34.2M Buy
73,527
+2,867
+4% +$1.34M 1.22% 19
2020
Q3
$31.2M Buy
70,660
+1,917
+3% +$846K 1.26% 19
2020
Q2
$28.6M Buy
68,743
+4,245
+7% +$1.76M 1.19% 22
2020
Q1
$18.3M Buy
64,498
+12,936
+25% +$3.67M 0.99% 35
2019
Q4
$16.8M Buy
51,562
+9,464
+22% +$3.07M 0.73% 48
2019
Q3
$12.4M Hold
42,098
0.61% 53
2019
Q2
$12.4M Buy
42,098
+23,553
+127% +$6.92M 0.61% 53
2019
Q1
$5.08M Buy
+18,545
New +$5.08M 0.54% 34